Collin Todd

Corporate Officer/Principal at ODYSSEY THERAPEUTICS, INC.

Net worth: - $ as of 31/07/2026

34 year

31 connections

Finance

Health Technology

Consumer Services

Profile

Collin Todd is currently Director at CTRL Therapeutics, Inc. and Senior VP-Strategy & Business Development at Odyssey Therapeutics, Inc. Formerly, Mr. Todd was an Analyst at OrbiMed Advisors Private Equity from 2015 to 2016 and an Analyst at Merrill Lynch, Pierce, Fenner & Smith, Inc. Education includes undergraduate studies at the University of California.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ODYSSEY THERAPEUTICS, INC. -.--%	08/05/2026	0 ( -.--% )	- $	31/07/2026

Collin Todd active positions

Companies	Position	Start
ODYSSEY THERAPEUTICS, INC.	Corporate Officer/Principal	01/06/2024
CTRL Therapeutics, Inc. CTRL Therapeutics, Inc. BiotechnologyHealth Technology Develops liquid biopsy platform that isolates circulating tumor cells from blood	Director/Board Member	-

All active positions of Collin Todd

Former positions of Collin Todd

Companies	Position	End
OrbiMed Advisors Private Equity OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies.	Private Equity Analyst	01/11/2016
Merrill Lynch, Pierce, Fenner & Smith, Inc. Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides brokerage services	Corporate Officer/Principal	-

See the detail of Collin Todd's experience

Training of Collin Todd

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Collin Todd's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
OrbiMed Advisors Private Equity OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies.	Finance
Merrill Lynch, Pierce, Fenner & Smith, Inc. Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides brokerage services	Finance
University of California University of California Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
CTRL Therapeutics, Inc. CTRL Therapeutics, Inc. BiotechnologyHealth Technology Develops liquid biopsy platform that isolates circulating tumor cells from blood	Health Technology
Odyssey Therapeutics, Inc. Odyssey Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for autoimmune and inflammatory diseases	Health Technology